Endocrinology · cellular technologies
Type 2 diabetes: treatment in China (Boao Lecheng)
The foundation of type 2 diabetes care is the same everywhere — diet, activity, weight and the medicines your endocrinologist prescribes. Nothing replaces it. At the same time, the list of technologies the Boao Lecheng zone regulator has permitted for clinical use includes treatment of type 2 diabetes with human umbilical cord mesenchymal stem cells. Here is a plain account of what that is, who it is considered for, and what not to expect.
About the condition
What happens in type 2 diabetes
Type 2 diabetes is a chronic metabolic disorder in which tissues respond less well to insulin (insulin resistance) and, over time, the pancreas can no longer compensate by producing more of the hormone. Blood glucose rises, and for a long time nothing is felt.
The danger is not a high reading on a given day but years of it: small and large vessels, nerves, eyes, kidneys and feet are affected. That is why treatment is judged by numbers rather than by how you feel — above all by glycated haemoglobin (HbA1c), which reflects average glucose over several months.
Type 2 diabetes is manageable. With changes to diet, weight loss, regular activity and well-chosen therapy, many people keep their readings in the target range for years. That is the foundation from which any conversation about additional methods begins.
Why people come
The situations we see most often
If one of these is yours, it is worth establishing the stage and the options.
- A diagnosis, but no system
Glucose has been raised for years and medicines are prescribed, yet there is no clear plan and no monitoring over time.
- HbA1c is not reaching target
Despite tablets and effort, glycated haemoglobin stays above the level your physician set.
- Doses keep rising
There are more medicines, insulin is being discussed, and you want to understand what else can be done.
- Signs of complications
Numb feet, worsening vision, changes in kidney tests — the extent needs assessing and the process needs stopping.
- You want the full picture
Metabolism, vessels, kidneys and eyes seen within a few days — and a plan, not scattered prescriptions.
- You are interested in cellular technologies
You have read about stem cells in diabetes and want a physician's measured view, not advertising.
Standard care first
What is normally done before anything else
We do not propose replacing proven treatment. On the contrary: without it, any next step loses its meaning.
The foundation of type 2 diabetes care is set out in international and national guidelines, and it does not change from country to country:
- Diet and weight loss — the strongest non-drug factors affecting glucose
- Regular physical activity — improves tissue sensitivity to insulin
- Metformin and modern medicines — glucose-lowering drugs chosen by an endocrinologist with weight, kidneys, heart and other conditions in mind
- Insulin by indication — when your own production is insufficient; it is part of therapy, not a “defeat”
- HbA1c monitoring and self-monitoring — targets are set individually by the physician
- Complication screening — eyes, kidneys, feet, vessels: regularly, even when nothing troubles you
Cellular programmes do not replace this foundation and do not remove medicines or insulin. They are considered separately, by indication and only on a physician's decision — as an addition, not an alternative.
Where a programme begins
No programme starts without a work-up
Diagnostics come first: they decide whether the method is indicated in your case and to what extent. From here there are two possible next steps.
The regenerative approach
What the cluster additionally considers
On medical grounds — as an addition to standard care, never instead of it.
- First — an objective picture
A full assessment: HbA1c, glycaemia, lipids, kidney function, vessel status, fundus examination, foot examination. Without these data no decision is made.
- Endocrinology review
A specialist physician in the cluster reviews your regimen as a whole — medicines, doses, targets, tolerance. A classic second-opinion request.
- A cellular technology permitted in the zone
The list of technologies the Boao Lecheng zone regulator has permitted for clinical use (published 22 March 2026) includes treatment of type 2 diabetes with human umbilical cord mesenchymal stem cells. It is applied by one of the cluster's hospitals. Indications are assessed by the physician after examination.
- A developing field — said plainly
Studies of cell therapy in type 2 diabetes are still small, and there is no registered medicine on this basis. Expectations are only those your physician discusses with you; we add nothing of our own.
Methods
Which directions may be considered
What suits your case is determined by a physician after diagnostics.
MSC therapy in detail
Mesenchymal stem cells: what they are, where they come from and how the protocol works in the cluster.
Comprehensive check-up
Metabolism, vessels, kidneys and eyes — the full picture within a few days.
Cellular and regenerative medicine
How the field is organised in the cluster and the legal framework it works within.
Plainly about the limits
When the regenerative route is not for you
This matters more than any marketing: knowing in advance when the method is not considered.
A cellular programme is not considered here if:
- Type 1 diabetes — a different disease with a different mechanism; the permitted technology does not apply to it
- Decompensation or ketoacidosis — an acute condition needs emergency care at home, not a journey
- Expecting insulin or tablets to be withdrawn — the programme sets no such goal, and no one will promise it
- Basic therapy has not been started — beginning with a cellular programme without diet, activity and medicines is not rational
- Pregnancy or planning one — care is led by your obstetrician and endocrinologist at home
- Active cancer or autoimmune processes, severe kidney or heart failure — contraindications are assessed individually by the physician
Plainly: for most people with type 2 diabetes the matter is resolved by proven therapy and lifestyle change. The cellular technology is an additional tool by indication, not an answer for everyone, and we will say so directly.
How it works
From your records to coming home
- 11. Records and tests
You send your records, HbA1c and tests over time, and a list of medicines with doses. We translate the documents for the cluster's physicians.
- 22. Preliminary assessment
The physician reviews the history, control and complications and says whether anything beyond adjusting therapy is worth considering. No diagnosis is made online.
- 33. Diagnostics on site
Full laboratory work-up, fundus, kidney, foot and vessel examination, an endocrinology consultation and assessment of contraindications.
- 44. The plan
The physician sets the plan: therapy, HbA1c targets, a monitoring schedule and — where indicated — a cellular programme.
- 55. Return and follow-up
You go home with a clear regimen and checkpoints; care with your endocrinologist at home continues, and we stay in touch.
Why here
What the Boao Lecheng cluster offers
- The technology is permitted here
The cellular technology for type 2 diabetes is on the zone regulator's list of technologies permitted for clinical use — work within the legal framework, not a “grey” practice.
- Diagnostics and treatment side by side
Laboratory, imaging and specialist physicians are available within a few days, with no pauses between stages.
- Controlled production
Cellular preparations are made in a certified laboratory to GMP standards, under state regulation.
- You pay the clinic directly
No mark-up on the medicine: we arrange the route, interpreting and support.
Common questions
The essentials
Send your scans — and get a straight answer
A specialist physician in the cluster will look at your stage and say whether the regenerative route is worth considering. The review is free; we do not diagnose online.